|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Texas Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing TexasLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
CardioVascular BioTherapeutics, Inc.
| | | Phone: | (972) 681-9368 | Year Established: | 1998 | Main Contact: | Mickael A. Flaa, President & CFO | | Other Contacts: | Laurence R. Meyerson Ph.D., Executive VP, R&D
| |
| Company Description | CVBT is a biopharmaceutical company developing protein drug candidates to address diseases such as diabetic wounds, severe coronary heart disease, and peripheral artery disease. The active pharmaceutical ingredient (API) in our drug candidates is FGF-1, a human protein that stimulates the growth of new blood vessels, thereby increasing the blood supply to ischemic organs and tissues. | |
|
|
|
|
|